Erudio Healtherudio.com
Drug
Atebimetinib trials: what clinicians said in public
An HCP commentary report on 1 clinical trial studying atebimetinib: MAPKeeper 301. It covers what clinicians said in public about one trial, on podcasts, videos and posts, every statement linked to its source.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| MAPKeeper 301 NCT07562152 · Immuneering Corporation | first-line metastatic pancreatic ductal adenocarcinoma | Phase 3 | 138 | 37 | Focused | Nov 1, 2026 | Preview |